
Events and Updates
Evolution of the UK Life Sciences Ecosystem:
Key Locations, Government Support, and Future Trends
The UK's life sciences sector is poised for continued growth, building on a strong foundation of academic excellence, government support, and industry collaboration. This report explores how the life sciences community can seize the opportunity to meet the evolving needs of life sciences companies by developing flexible, inclusive, and sustainable workspaces. Through insightful case studies and analysis, the report highlights the importance of strategic investment in infrastructure and partnerships. As the UK attracts global investment and leverages its rich scientific heritage, the country remains a leading force in life sciences, positioned to drive the next generation of breakthroughs.
Builds Bio+ membership expansion into London/UK: Bridging all segments of the life science ecosystem
London is emerging as a vital center for life sciences, part of the UK's 'Golden Triangle' alongside Oxford and Cambridge, spurred by a surge in sector investment post-pandemic. This surge includes firms in pharmaceuticals, biotechnology, and genomics seeking space for research and expansion.
As an extension of the Builds Bio+ nonprofit membership-driven organization established in New York and Philadelphia, London/UK Builds Bio+ is dedicated to bringing the life sciences innovation community together, serving as the go-to place to find information about and assistance with growing, building and locating life science companies in the area.
This expansion brings together 11 founding members from industry, government, and academia to drive innovation and growth in the UK and Europe while strengthening transatlantic ties with the Greater New York and Philadelphia regions.
Meet the Founding Members of Our London/UK Chapter
Read the Builds Bio+ London/UK Chapter Press Release
The London/UK chapter marks a significant step in Builds Bio+’s evolution into an international organization, creating a dynamic ecosystem that leverages the strengths of both the UK and US life sciences markets. Regular virtual events will connect members from the New York Metro, Philadelphia, and London/UK chapters, fostering collaboration and knowledge sharing.


The founding members of the London/UK chapter represent a diverse cross-section of the life sciences and real estate sectors:
- University College London
- SC1 London
- Mace
- AECOM
- British Land
- Galileo Labs
- Macfarlanes LLP
- Linesight
- Merrick & Company
- Precis Advisory
- PLP Architecture
Interested in Becoming a Builds Bio+ London/UK Member?
The goal of London/UK Builds Bio+ is to educate an integrated base of life science and real estate professionals, increase the visibility of commercial life sciences opportunities, and jump start life science real estate development in the London area in a manner that will foster a large and growing economics cluster.
GET YOUR COPY!
Evolution of the New York Life Sciences Market
The New York/London Life Sciences Study Tour Research Report
This report tracks 25 years of NYC's life sciences growth, highlighting infrastructure development and initiatives that propelled it as a global leader in research and innovation, offering insights for other aspiring life science hubs.
"We are convinced that both the talent in London and the ecosystem will enable us to build a very vibrant hub."
– Dr. Hal Barron
Chief Scientific Officer, GSK
London/UK Builds Bio+
London/UK boasts an exceptional ecosystem for life sciences, featuring an interlinked community of top-tier universities, prestigious research institutions, healthcare services, medical nonprofits, inventive small enterprises, and major international corporations. This robust network makes London/UK a prime target for innovation and investments in the life sciences sector.

A historic beacon of life sciences innovation
London's storied past as a hub for medical and biological innovation continues into the present, where it now stands in partnership with Oxford and Cambridge as the 'Golden Triangle'—a globally recognized nexus for the life sciences industry. This trio of cities collectively represents a powerhouse of research and development, driving forward the frontiers of knowledge in medicine and biology on the world stage.
One of the main reasons why London is a great place to scale is its well-connected clusters, both locally and globally. From the bustling city centre to all four corners of the capital you find world-leading clusters of excellence that offer anything from lab and incubation space, to partnership opportunities and the ability to attract and access top talent.
Some new/proposed investments in London's life sciences sector include:
- the Francis Crick Institute – bringing together 1,500 scientists and support staff, with a focus on finding new ways to treat, diagnose and prevent a range of illnesses
- Imperial College London’s White City Campus – co-locating researchers, businesses and higher education partners on a 25-acre site; the new UK Dementia Research Institute (UK DRI) also hosted on this campus
- the London Cancer Hub – a partnership between the Institute of Cancer Research and London Borough of Sutton, which aims to be one of the world’s leading districts specializing in cancer research and treatment
- AstraZeneca’s new global R&D Centre in Cambridge, where the company already has 2,000 employees

"We are pioneering cutting-edge technologies, life-changing treatments and ground-breaking programs – the capital offers a huge number of opportunities for investors to support creativity across our thriving life sciences sector."
– Rajesh Agrawal
Deputy Mayor of London for Business

Steering Committee

Nancy J Kelley
Nancy J Kelley + Associates

Mitch W. Simpler
Jaros, Baum & Bolles

Nick Barnes
Macfarlanes LLP

Timothy Burke
Merrick & Company

Dean Cadby
Langan UK

Joseph Casey
SC1 London

Simon Hepher Davies

Thomas Holbrow
Mace Group

Bennett John
British Consulate General New York

Dr. Jane Kinghorn
UCL

Faaiza Lalji
Precis Advisory

Professor Sir Robert Lechler
SC1 London

Ryan Matenchuk
Galileo Labs

Priya Shah
Linesight

Alison Wring
AECOM





















































